MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Imunon Inc

Slēgts

0.72 -7.69

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.7

Max

0.77

Galvenie mērījumi

By Trading Economics

Darbinieki

25

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+1672.15% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 13. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4M

15M

Iepriekšējā atvēršanas cena

8.41

Iepriekšējā slēgšanas cena

0.72

Imunon Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 7. jūl. 15:29 UTC

Galvenie tirgus virzītāji

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

2025. g. 7. jūl. 23:44 UTC

Tirgus saruna

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

2025. g. 7. jūl. 23:44 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 7. jūl. 23:41 UTC

Tirgus saruna

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

2025. g. 7. jūl. 23:19 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 7. jūl. 23:19 UTC

Tirgus saruna

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

2025. g. 7. jūl. 22:20 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 7. jūl. 22:20 UTC

Tirgus saruna

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

2025. g. 7. jūl. 21:34 UTC

Iegādes, apvienošanās, pārņemšana

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

2025. g. 7. jūl. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 7. jūl. 20:45 UTC

Iegādes, apvienošanās, pārņemšana

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

2025. g. 7. jūl. 20:16 UTC

Tirgus saruna

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

2025. g. 7. jūl. 19:37 UTC

Tirgus saruna

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

2025. g. 7. jūl. 19:12 UTC

Tirgus saruna

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

2025. g. 7. jūl. 18:33 UTC

Tirgus saruna

Gold Flat as Investors Assess Market Direction -- Market Talk

2025. g. 7. jūl. 18:27 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 7. jūl. 16:53 UTC

Peļņas

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

2025. g. 7. jūl. 16:30 UTC

Tirgus saruna

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

2025. g. 7. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 7. jūl. 16:05 UTC

Iegādes, apvienošanās, pārņemšana

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

2025. g. 7. jūl. 15:41 UTC

Tirgus saruna

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

2025. g. 7. jūl. 15:41 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 7. jūl. 15:40 UTC

Tirgus saruna

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

2025. g. 7. jūl. 15:30 UTC

Tirgus saruna

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

2025. g. 7. jūl. 15:18 UTC

Tirgus saruna

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

2025. g. 7. jūl. 15:14 UTC

Iegādes, apvienošanās, pārņemšana

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

2025. g. 7. jūl. 15:00 UTC

Iegādes, apvienošanās, pārņemšana

GSK Completes Acquisition of Efimosfermin

2025. g. 7. jūl. 14:52 UTC

Tirgus saruna

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

2025. g. 7. jūl. 14:51 UTC

Tirgus saruna

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

2025. g. 7. jūl. 14:45 UTC

Tirgus saruna

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Salīdzinājums

Cenas izmaiņa

Imunon Inc Prognoze

Cenas mērķis

By TipRanks

1672.15% augšup

Prognoze 12 mēnešiem

Vidējais 14 USD  1672.15%

Augstākais 14 USD

Zemākais 14 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Imunon Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

1

Pirkt

1

Turēt

0

Pārdot

Finanšu rādītāji

$

Par Imunon Inc

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.